Atlas Trials

The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD

Clinical trial NCT05374291 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05374291
Sponsor
University Medical Center Groningen
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Disease, ChronicRenal Transplant FailureHeart FailureKidney FailureDeath
Start date
2022-11-08
Primary completion
2027-07-01
Enrollment
1750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.